Status:
RECRUITING
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Lead Sponsor:
UNC Lineberger Comprehensive Cancer Center
Collaborating Sponsors:
Conquer Cancer Foundation
Conditions:
Metastatic Breast Cancer
End of Life
Eligibility:
All Genders
Brief Summary
I this qualitative study, Investigators will conduct semi-structured interviews with clinicians that are involved in the care of patients with breast cancer to evaluate the acceptability, appropriaten...
Detailed Description
If this study is successful, Investigators will implement an MBC-specific prognostic tool to help clinicians identify patients who are at high risk of death in the next 30 days. Based on the input fro...
Eligibility Criteria
Inclusion
- Verbal informed consent obtained to participate in the study.
- Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
- Physician, nurse practitioner, physician assistant, or nurse navigator
- At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.
Exclusion
- Non-English Speaking
Key Trial Info
Start Date :
July 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 10 2027
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05440929
Start Date
July 7 2022
End Date
August 10 2027
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599